Filing Details

Accession Number:
0001415889-24-016259
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-10 17:55:54
Reporting Period:
2024-06-07
Accepted Time:
2024-06-10 17:55:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1287098 Maxcyte Inc. MXCT Services-Commercial Physical & Biological Research (8731) 522210438
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1874571 Maher Masoud C/O Maxcyte, Inc.
9713 Key West Avenue, Suite 400
Rockville MD 20850
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-06-07 29,557 $4.87 29,557 No 4 P Direct
Common Stock Acquisiton 2024-06-10 70,443 $4.90 100,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.84 to $4.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.77 to $5.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.